Matches in SemOpenAlex for { <https://semopenalex.org/work/W4378528191> ?p ?o ?g. }
- W4378528191 endingPage "2948" @default.
- W4378528191 startingPage "2948" @default.
- W4378528191 abstract "Despite the recent approval of novel immunotherapies, such as immunomodulatory drugs, proteasome inhibitors and anti-CD38 monoclonal antibodies, Multiple Myeloma (MM) remains incurable, and the acquisition of triple-refractoriness leads to really dismal outcomes in even earlier lines of therapy. More recently, innovative therapeutic strategies targeting B cell maturation antigen (BCMA), highly expressed on the plasma cell surface, are drawing different future landscapes in terms of effectiveness and outcomes. Belantamab Mafodotin, a first-in-class anti-BCMA antibody–drug conjugate, demonstrated good efficacy and safety profile in triple-refractory patients in the phase 2 DREAMM-2 trial, and it was approved for the treatment of MM triple-exposed patients with >4 prior lines of therapy. Here, starting from Belantamab Mafodotin clinical trials and also exploring combination studies and different schedules in order to improve its efficacy and toxicity, we focused on real-life experiences all over the world, which have confirmed clinical trial data and encourage further Belantamab Mafodotin investigations." @default.
- W4378528191 created "2023-05-28" @default.
- W4378528191 creator A5017681466 @default.
- W4378528191 creator A5045814742 @default.
- W4378528191 creator A5069805862 @default.
- W4378528191 creator A5072401592 @default.
- W4378528191 creator A5083644983 @default.
- W4378528191 date "2023-05-27" @default.
- W4378528191 modified "2023-09-25" @default.
- W4378528191 title "Belantamab Mafodotin: From Clinical Trials Data to Real-Life Experiences" @default.
- W4378528191 cites W1902692042 @default.
- W4378528191 cites W1988265934 @default.
- W4378528191 cites W2144058399 @default.
- W4378528191 cites W2337546548 @default.
- W4378528191 cites W2512106959 @default.
- W4378528191 cites W2528329272 @default.
- W4378528191 cites W2531611585 @default.
- W4378528191 cites W2592248309 @default.
- W4378528191 cites W2755114342 @default.
- W4378528191 cites W2772566228 @default.
- W4378528191 cites W2801640510 @default.
- W4378528191 cites W2809887713 @default.
- W4378528191 cites W2898306454 @default.
- W4378528191 cites W2900068404 @default.
- W4378528191 cites W2923666301 @default.
- W4378528191 cites W2929340554 @default.
- W4378528191 cites W2947874495 @default.
- W4378528191 cites W2948728876 @default.
- W4378528191 cites W2969931905 @default.
- W4378528191 cites W2972402953 @default.
- W4378528191 cites W2988470278 @default.
- W4378528191 cites W2988984460 @default.
- W4378528191 cites W2995934717 @default.
- W4378528191 cites W2996514972 @default.
- W4378528191 cites W2999692671 @default.
- W4378528191 cites W3008450454 @default.
- W4378528191 cites W3043410628 @default.
- W4378528191 cites W3044244229 @default.
- W4378528191 cites W3083502363 @default.
- W4378528191 cites W3087735636 @default.
- W4378528191 cites W3095595439 @default.
- W4378528191 cites W3096867320 @default.
- W4378528191 cites W3105812043 @default.
- W4378528191 cites W3113262110 @default.
- W4378528191 cites W3123845019 @default.
- W4378528191 cites W3133229959 @default.
- W4378528191 cites W3151545398 @default.
- W4378528191 cites W3164708987 @default.
- W4378528191 cites W3164873993 @default.
- W4378528191 cites W3170038569 @default.
- W4378528191 cites W3176532045 @default.
- W4378528191 cites W3177941998 @default.
- W4378528191 cites W3183441818 @default.
- W4378528191 cites W3191792069 @default.
- W4378528191 cites W4200179980 @default.
- W4378528191 cites W4221027512 @default.
- W4378528191 cites W4281631369 @default.
- W4378528191 cites W4281714381 @default.
- W4378528191 cites W4282033105 @default.
- W4378528191 cites W4282580226 @default.
- W4378528191 cites W4283375647 @default.
- W4378528191 cites W4293092306 @default.
- W4378528191 cites W4295424675 @default.
- W4378528191 cites W4303419031 @default.
- W4378528191 cites W4309215158 @default.
- W4378528191 cites W4310099070 @default.
- W4378528191 cites W4310106200 @default.
- W4378528191 cites W4310107882 @default.
- W4378528191 cites W4310108235 @default.
- W4378528191 cites W4310117565 @default.
- W4378528191 cites W4310119541 @default.
- W4378528191 cites W4310127231 @default.
- W4378528191 cites W4310127264 @default.
- W4378528191 cites W4310127740 @default.
- W4378528191 cites W4310159247 @default.
- W4378528191 cites W4366463565 @default.
- W4378528191 doi "https://doi.org/10.3390/cancers15112948" @default.
- W4378528191 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37296910" @default.
- W4378528191 hasPublicationYear "2023" @default.
- W4378528191 type Work @default.
- W4378528191 citedByCount "1" @default.
- W4378528191 countsByYear W43785281912023 @default.
- W4378528191 crossrefType "journal-article" @default.
- W4378528191 hasAuthorship W4378528191A5017681466 @default.
- W4378528191 hasAuthorship W4378528191A5045814742 @default.
- W4378528191 hasAuthorship W4378528191A5069805862 @default.
- W4378528191 hasAuthorship W4378528191A5072401592 @default.
- W4378528191 hasAuthorship W4378528191A5083644983 @default.
- W4378528191 hasBestOaLocation W43785281911 @default.
- W4378528191 hasConcept C121332964 @default.
- W4378528191 hasConcept C126322002 @default.
- W4378528191 hasConcept C142424586 @default.
- W4378528191 hasConcept C143998085 @default.
- W4378528191 hasConcept C2776364478 @default.
- W4378528191 hasConcept C2780035454 @default.
- W4378528191 hasConcept C535046627 @default.
- W4378528191 hasConcept C71924100 @default.
- W4378528191 hasConcept C87355193 @default.